Capital Analysts LLC’s Boston Scientific BSX Stock Holding History

Capital Analysts LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.38M	Buy	50,061 +602	+1%	+$64.7K	0.18%	105
2025 Q1	$4.99M	Buy	49,459 +822	+2%	+$82.9K	0.19%	102
2024 Q4	$4.34M	Buy	48,637 +728	+2%	+$65K	0.17%	106
2024 Q3	$4.01M	Buy	47,909 +3,697	+8%	+$310K	0.16%	114
2024 Q2	$3.41M	Buy	44,212 +2,027	+5%	+$156K	0.15%	117
2024 Q1	$2.89M	Buy	42,185 +974	+2%	+$66.7K	0.13%	132
2023 Q4	$2.38M	Buy	41,211 +868	+2%	+$50.2K	0.12%	146
2023 Q3	$2.13M	Buy	40,343 +302	+0.8%	+$15.9K	0.12%	144
2023 Q2	$2.17M	Sell	40,041 -626	-2%	-$33.9K	0.12%	147
2023 Q1	$2.04M	Sell	40,667 -12,954	-24%	-$648K	0.12%	155
2022 Q4	$2.48M	Sell	53,621 -1,809	-3%	-$83.7K	0.15%	134
2022 Q3	$2.15M	Sell	55,430 -296	-0.5%	-$11.5K	0.15%	135
2022 Q2	$2.08M	Sell	55,726 -350	-0.6%	-$13K	0.14%	141
2022 Q1	$2.48M	Buy	56,076 +1,694	+3%	+$75K	0.16%	127
2021 Q4	$2.31M	Buy	54,382 +1,135	+2%	+$48.2K	0.14%	143
2021 Q3	$2.31M	Buy	53,247 +2,097	+4%	+$91K	0.15%	135
2021 Q2	$2.19M	Buy	51,150 +11,872	+30%	+$508K	0.15%	138
2021 Q1	$1.52M	Buy	39,278 +4,761	+14%	+$184K	0.1%	167
2020 Q4	$1.24M	Buy	34,517 +3,979	+13%	+$143K	0.11%	156
2020 Q3	$1.17M	Buy	30,538 +2,403	+9%	+$91.8K	0.11%	149
2020 Q2	$988K	Buy	28,135 +37	+0.1%	+$1.3K	0.1%	154
2020 Q1	$917K	Sell	28,098 -559	-2%	-$18.2K	0.11%	147
2019 Q4	$1.3M	Buy	28,657 +1,391	+5%	+$62.9K	0.13%	153
2019 Q3	$1.11M	Buy	27,266 +147	+0.5%	+$5.98K	0.12%	159
2019 Q2	$1.17M	Sell	27,119 -1,605	-6%	-$69K	0.13%	147
2019 Q1	$1.1M	Sell	28,724 -8,932	-24%	-$343K	0.13%	142
2018 Q4	$1.33M	Sell	37,656 -3,992	-10%	-$141K	0.17%	100
2018 Q3	$1.6M	Buy	41,648 +691	+2%	+$26.6K	0.18%	98
2018 Q2	$1.34M	Sell	40,957 -76	-0.2%	-$2.49K	0.16%	102
2018 Q1	$1.12M	Buy	41,033 +2,322	+6%	+$63.4K	0.14%	123
2017 Q4	$960K	Buy	+38,711	New	+$960K	0.12%	142